Navigating Founders’ Fundraising Journeys: Q&A with Adam Caplan on his New Role as Investment Manager
Adam Caplan has been at Halcyon for nearly three years, working on developing and executing the curriculums for our residential accelerator programs. Adam got his start at the Aga Khan Foundation , where he helped create their first impact investment fund. He then led research initiatives at several global incubators and accelerators, mentoring founding teams and mobilizing investments for mission-driven startups in the US, South Asia, and East Africa.
At Halcyon, Adam was involved in a major transition as our organization shifted from a sector-agnostic lens to fellowships along three key verticals—Health, Climate, and EquityTech—adapting our programming to source relevant advisors and workshop presenters, facilitate peer review sessions, and conduct weekly mentoring support with each founder in his cohorts. In addition, Adam organized and curated events to gather networks of partners, stakeholders, and investors to connect with founders in-residency.
In May 2025, Adam began a brand-new role at Halcyon: Investment Manager. Check out this Q&A to learn more about how Halcyon is expanding our support for our founders and alumni in their fundraising journeys:
A lot of founders, especially first-time founders, approach fundraising with a bit of a one-size-fits-all strategy. We have this idea of what the venture capital ecosystem and the investment lifecycle for startups looks like—we generally think of it as bootstrapping, to friends and family, to a seed round, to a Series A—and so a lot of founders come in with the last slide of their pitch deck being an ask for $750K. And while that's not necessarily a bad thing, you can't take a one-size-fits-all approach to anything, and certainly not for individual company stories. A lot of the time, what people realize throughout the Halcyon program is that they need to update, amend, or rethink their fundraising strategy—the amount, the timeline, and perhaps the type of capital.
I’m thinking about this role across three main areas:
An important note is that my role is located within the Programs team at Halcyon and is distinct from our sister organization, Halcyon Venture Partners (HVP). There will be a lot of collaboration between myself and the HVP team, but in many cases, it will be helping founders who aren't going to be the right fit for HVP or other VC funds understand where to go next. This will be an exciting iterative process as we gain a better understanding of the investment needs of our founders and alumni and how myself and the HVP team—either through investment capital from their fund or their other support—can help them in their fundraising journeys.
When you look upstream at earlier stage companies, even in the best of times, VC follows a pretty standard portfolio model where most of the investments are not going to be successful, and so you need to invest only in companies that you can see having parabolic or exponential returns. Most ventures are not going to have this scalable trajectory or the huge market size that VC tends to chase. On top of that, a lot of the impact-driven companies that are coming through Halcyon are trying to increase access to goods and services for populations that haven't had them before. This means that oftentimes, there's some significant early behavior change and adoption challenges they face that may require grant capital or subsidy for customer discovery and to figure out the right distribution model for them. So, it might be that they're not the right fit for VC ever, or it might be that they're not the right fit for VC at the early stage they're coming into Halcyon. One of the things we want to do is help founders understand whether VC ought to be part of their fundraising strategy, and if so, at what point in their business development that might be appropriate.
Oncovana (2025 Health Fellowship) met an angel investor at our Investor Dinner, and they drafted a term sheet right there at the table. That Investor event was itself an experiment—we wanted to continue improving on Halcyon’s approach to building and tapping into our investor network to create more value for our founders. So, we reconceived what a program’s investor event should be, who should be invited, and what its end goal was, and there were a lot of valuable connections made.
Personally, I worked with the Oncovana team in the lead-up to the event on how to tailor their pitch and who was going to be in the room. Looking more broadly, Oncovana came into Halcyon wanting to raise around $500K, but by the end, they actually decided to raise just $40K to build out their MVP and get into a pilot study with their design partner, and then push off raising their seed round until the end of 2025 or early next year. That kind of journey is kind of exactly what I want to work with founders on. The journey—way before you raise money—is figuring out, do I need to be raising money? If so, when, how much, and from whom?